Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Atara Biotherapeutics, Inc. - Common Stock (NQ: ATRA ) 13.33 +1.13 (+9.26%) Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 80,924 Open 12.37 Bid (Size) 12.20 (1) Ask (Size) 13.30 (3) Prev. Close 12.20 Today's Range 12.16 - 13.39 52wk Range 6.500 - 39.50 Shares Outstanding 101,102,152 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference November 27, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference November 13, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Performance YTD +11.11% +11.11% 1 Month +9.98% +9.98% 3 Month +80.14% +80.14% 6 Month +82.73% +82.73% 1 Year -4.43% -4.43% More News Read More Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress November 12, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Earnings Scheduled For November 12, 2024 November 12, 2024 Via Benzinga Insights into Atara Biotherapeutics's Upcoming Earnings November 11, 2024 Via Benzinga Sidoti Events, LLC's Virtual November Micro-Cap Conference November 12, 2024 Via ACCESSWIRE Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 November 05, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) October 04, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) September 06, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference September 04, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earnings September 04, 2024 Via Benzinga Exposures Fossil Fuels Atara Biotherapeutics (ATRA) Stock Is Up 20%: What's Going On? September 04, 2024 Via Benzinga Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket September 04, 2024 Via Benzinga Atara Biotherapeutics Announces $36 Million Registered Direct Offering September 03, 2024 From Atara Biotherapeutics, Inc. Via Business Wire ATRA Stock Earnings: Atara Biotherapeutics Misses EPS, Misses Revenue for Q2 2024 August 12, 2024 Via InvestorPlace Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update August 12, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Atara Biotherapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference August 07, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease July 17, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) July 05, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum July 03, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) Wins Prix Galien International Award for Best Product for Orphan/Rare Diseases June 21, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 17, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session June 17, 2024 Via Benzinga Atara Biotherapeutics Announces 1-for-25 Reverse Stock Split June 17, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) June 07, 2024 From Atara Biotherapeutics, Inc. Via Business Wire Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
